Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JAMA Internal Medicine

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamainternmed.2016.9539PMID 28241231PMCID PMC5433755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gonadal steroid-dependent effects on bone turnover and bone mineral density in men.

  2016cited by this paper
• Effects of Testosterone Treatment in Older Men.

  2016cited by this paper
• Recruitment and Screening for the Testosterone Trials.

  2015cited by this paper
• Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-MRI in the distal tibia of men with hypopituitarism.

  2014cited by this paper
• The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men

  2014cited by this paper
• Title Erratum : The Testosterone Trials : Seven coordinated trials of testosterone treatment in elderly men

  2014cited by this paper
• Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.

  2013cited by this paper
• Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

  2013cited by this paper
• Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans

  2012cited by this paper
• QCT measures of bone strength at the thoracic and lumbar spine: The Framingham study

  2012cited by this paper
• Femoral strength in osteoporotic women treated with teriparatide or alendronate.

  2012cited by this paper
• Relation of Vertebral Deformities to Bone Density, Structure, and Strength

  2010cited by this paper
• Estimation of absolute fracture risk among middle-aged and older men and women: the EPIC-Norfolk population cohort study

  2009cited by this paper
• Finite Element Analysis of the Proximal Femur and Hip Fracture Risk in Older Men

  2009cited by this paper
• Long‐term changes in bone mineral density and predicted fracture risk in patients receiving androgen‐deprivation therapy for prostate cancer, with stratification of treatment based on presenting values

  2009cited by this paper
• Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

  2008cited by this paper
• A Population‐Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men

  2007cited by this paper
• Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis

  2006cited by this paper
• DHEA in elderly women and DHEA or testosterone in elderly men.

  2006cited by this paper
• Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.

  2005cited by this paper
• Risk of fracture after androgen deprivation for prostate cancer.

  2005cited by this paper
• Effect of Testosterone Replacement on Trabecular Architecture in Hypogonadal Men

  2005cited by this paper
• Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.

  2005cited by this paper
• Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

  2004cited by this paper
• Differential effects of androgens and estrogens on bone turnover in normal men.

  2003cited by this paper
• Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography.

  2003cited by this paper
• Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone

  2002cited by this paper
• Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.

  2001cited by this paper
• Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

  2001cited by this paper
• Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.

  2000cited by this paper
• Posterior‐Anterior and Lateral Dual‐Energy X‐Ray Absorptiometry for the Assessment of Vertebral Osteoporosis and Bone Loss Among Older Men

  2000cited by this paper
• Effects of testosterone replacement in hypogonadal men.

  2000cited by this paper
• Effect of testosterone treatment on bone mineral density in men over 65 years of age.

  1999cited by this paper
• Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

  1997cited by this paper
• Effect of testosterone and estradiol in a man with aromatase deficiency.

  1997cited by this paper
• Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

  1996cited by this paper
• Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

  1994cited by this paper
• The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men.

  1990cited by this paper
• The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation.

  1990cited by this paper
• Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.

  1987cited by this paper
• Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism

  1987cited by this paper
• Osteoporosis in men with hyperprolactinemic hypogonadism.

  1986cited by this paper
• Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

  1975cited by this paper
• Minimization: A new method of assigning patients to treatment and control groups

  1974cited by this paper

• Testosterone Replacement Therapy in Athletes: Implications for Injury Recovery and Musculoskeletal Performance

  2026cites this paper
• Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies.

  2026cites this paper
• Psoas muscle mass measurement in assessment of imminent fracture risk after vertebral fracture: a single-center case-control study

  2026cites this paper
• Androgens as the “old age stick” in skeletal muscle

  2025cites this paper
• Testosterone and Male Bone Health: A Puzzle of Interactions.

  2025cites this paper
• PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men

  2025cites this paper
• Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism.

  2025cites this paper
• Testosterone replacement reduces morbidity and mortality for most patients with cirrhosis.

  2025cites this paper
• Male Hypogonadism: The Korean Society of Men's Health and Aging Position Statement

  2025influential citation
• The relationship between testosterone replacement therapy and incidence of proximal humerus fractures in men: a matched retrospective analysis

  2025cites this paper
• Long-Term Cardiovascular Safety of Testosterone-Replacement Therapy in Middle-Aged and Older Men: A Meta-analysis of Randomized Controlled Trials

  2025influential citation
• Riscos e efeitos do uso abusivo de esteroides anabolizantes androgênicos entre jovens e adultos

  2025cites this paper
• Advances in the management of osteoporosis

  2025cites this paper
• Clinical practice guidelines for the management of differences of sex development in Japan

  2025cites this paper
• Osteoporosis secundaria

  2025cites this paper
• Long-Term Testosterone Shows Cardiovascular Safety in Men With Testosterone Deficiency in Electronic Health Records

  2025cites this paper
• Testosterone Replacement Therapy Is Not Associated with Greater Revision Rates in Reverse Total Shoulder Arthroplasty

  2025cites this paper
• Injury and Poisoning Profile in Anabolic Steroid Users.

  2025cites this paper
• Benefits of Testosterone Hormone in the Human Body: A Systematic Review

  2025cites this paper
• Testosterone Replacement Therapy Is Associated With Increased Incidence Rate of Vertebral Fractures: A Matched Retrospective Analysis

  2025cites this paper
• Clinical practice guidelines for the management of differences of sex development in Japan

  2025cites this paper
• Impact of Testosterone on Male Health: A Systematic Review

  2025cites this paper
• Testosterone Replacement Therapy in Men Aged 50 and Above: A Narrative Review of Evidence-Based Benefits, Safety Considerations, and Clinical Recommendations

  2025influential citation
• Circadian Rhythm: Biological Functions, Diseases, and Therapeutic Targets

  2025cites this paper
• Testosterone-induced erythrocytosis: addressing the challenge of metabolic syndrome and widely prescribed SGLT2-inhibitor drugs

  2025cites this paper
• Association Between Long-Term Testosterone Exposure and Major Adverse Cardiovascular Events in Aging Men

  2025cites this paper
• Testosterone Therapy in Adult Males with Hypogonadism.

  2025cites this paper
• Osteoporosis in Men: an Overlooked Patient Population

  2025cites this paper
• Late-onset hypogonadism: current methods of clinical diagnosis and treatment in Japan

  2025cites this paper
• A case–control study based on the National Health and Nutrition Examination Survey to evaluate the effects of human papilloma virus on bone health in women

  2025cites this paper
• Effects of Romosozumab on Bone Strength Around a Pedicle Screw as Evaluated by Biomechanical Computed Tomography-Based Virtual Stress Tests in Postmenopausal Women

  2025cites this paper
• Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs

  2025cites this paper
• Sexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X‐Linked Adrenoleukodystrophy

  2025cites this paper
• Toward Sex-Specific Biomaterials Innovation: A Perspective

  2025cites this paper
• Diagnosis and management of male hypogonadism in Germany

  2025cites this paper
• Testosterone Replacement Therapy for Testosterone Deficiency in Older Men.

  2025cites this paper
• Endogenous Testosterone, Testosterone Treatment, and Cardiovascular Health Outcomes in Men

  2025cites this paper
• Crosstalk between androgen receptor and protein kinase G signaling in bone: implications for osteoporosis therapy.

  2025cites this paper
• The impact of a selective androgen receptor modulator (RAD140) on frailty and underlying mechanisms in older male and female C57Bl/6 mice.

  2025cites this paper
• Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases.

  2024cites this paper
• Testosteron – „Benzin“ für den alten Mann?

  2024cites this paper
• Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia

  2024cites this paper
• Does Testosterone Replacement Therapy Prevent Bone Fractures in Hypogonadal Men?

  2024cites this paper
• Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments

  2024cites this paper
• Dealing with the “T” (testosterone)

  2024cites this paper
• Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study

  2024cites this paper
• Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.

  2024cites this paper
• Testosterone replacement therapy: clinical considerations

  2024cites this paper
• Gestational vitamin D and offspring fracture risk: do associations persist into mid adolescence?

  2024cites this paper
• Insights and implications of sexual dimorphism in osteoporosis

  2024cites this paper
• Fine Particulate Matter and Osteoporosis: Evidence, Mechanisms, and Emerging Perspectives.

  2024cites this paper
• Osteoporosis in older men

  2024cites this paper
• Indications for testosterone therapy in men

  2024cites this paper
• Male hypogonadism: pathogenesis, diagnosis, and management.

  2024cites this paper
• Testosterone deficiency and chronic kidney disease

  2024cites this paper
• Testosterone: A Review for Orthopaedic Surgeons.

  2024cites this paper
• Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis

  2024cites this paper
• Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes

  2024cites this paper
• Associations of Serum Testosterone and SHBG With Incident Fractures in Middle-aged to Older Men

  2024cites this paper
• Evidence-Based Guideline for the management of osteoporosis in men

  2024cites this paper
• Bone microarchitectural alterations associated with spinal cord injury: Relation to sex hormones, metabolic factors, and loading.

  2024cites this paper
• In the Land of Not-Unhappiness: On the State-of-the-Art of Targeting Aging and Age-related Diseases by Biomedical Research.

  2024cites this paper
• Testosterone Treatment and Fractures in Men with Hypogonadism.

  2024cites this paper
• Testosterone Treatment and Fractures in Men with Hypogonadism. Reply.

  2024cites this paper
• Breaking News - Testosterone Treatment and Fractures in Older Men.

  2024cites this paper
• Testosterone therapy in older men: clinical implications of recent landmark trials.

  2024cites this paper
• Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality

  2024cites this paper
• Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome

  2024cites this paper
• Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

  2024cites this paper
• Whether exercises and testosterone replacement therapy support a treatment for cardiovascular and atherosclerotic patients with iliac artery stenosis and low total testosterone and high-density lipoprotein cholesterol after endovascular procedure?

  2023cites this paper
• The impact of testosterone in men's health.

  2023cites this paper
• Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration

  2023cites this paper
• The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice

  2023cites this paper
• Bone quality in endocrine diseases: determinants and clinical relevance

  2023cites this paper
• Gaps in evidence on treatment of male osteoporosis: a Research Agenda

  2023cites this paper
• Research advances in crosstalk between muscle and bone in osteosarcopenia (Review)

  2023cites this paper
• Endocrine complications of anorexia nervosa

  2023cites this paper
• Roles of sex hormones in mediating the causal effect of vitamin D on osteoporosis: A two-step Mendelian randomization study

  2023cites this paper
• Male Reproduction and Aging.

  2023cites this paper
• Genetic analyses implicate complex links between adult testosterone levels and health and disease

  2023cites this paper
• Approach to the Patient: Pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta.

  2023cites this paper
• Role of hormones in bone remodeling in the craniofacial complex: A review

  2023cites this paper
• Aging and Bone Metabolism.

  2023cites this paper
• The risks of testosterone therapy

  2023cites this paper
• Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management

  2023influential citation
• Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer.

  2023cites this paper
• Pros and cons of hormone replacement therapy

  2023cites this paper
• Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia

  2023cites this paper
• Testosterone Replacement Therapy for Treatment of Osteoporosis in Men

  2023cites this paper
• Drug Delivery and Therapy Strategies for Osteoporosis Intervention

  2023cites this paper
• Sarcopenia, osteoporosis and frailty.

  2023cites this paper
• The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis

  2023cites this paper
• EMAS position statement: Testosterone replacement therapy in older men.

  2023cites this paper
• Summary of the clinical practice manual for late‐onset hypogonadism

  2023cites this paper
• Cardiovascular Safety of Testosterone-Replacement Therapy.

  2023cites this paper
• Cardiovascular safety of testosterone replacement therapy

  2023cites this paper
• Testosterone and aging male, a perspective from a developing country

  2023cites this paper
• Immune checkpoint inhibitor-related hypophysitis.

  2022cites this paper
• Secondary Osteoporosis and Metabolic Bone Diseases

  2022cites this paper
• Vitamin D in Osteosarcopenic Obesity

  2022cites this paper